OPTIMIZED ANTIBODIES THAT TARGET CD19
The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of us...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Croatian English |
Published |
05.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of using said antibodies. |
---|---|
AbstractList | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of using said antibodies. |
Author | Pong, Erik WeiKing Richards, John O Desjarlais, John R Lazar, Gregory Alan Karki, Sher Bahadur Zhukovsky, Eugene Alexander Bernett, Matthew J Chu, Seung Yup |
Author_xml | – fullname: Bernett, Matthew J – fullname: Richards, John O – fullname: Zhukovsky, Eugene Alexander – fullname: Lazar, Gregory Alan – fullname: Karki, Sher Bahadur – fullname: Pong, Erik WeiKing – fullname: Desjarlais, John R – fullname: Chu, Seung Yup |
BookMark | eNrjYmDJy89L5WRQ9Q8I8fT1jHJ1UXD0C_F08nfxdA1WCPFwDFEIcQxydw1RcHYxtORhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfEeQQFGBobGBsaGJiEhRsbEqQIAEkkmLg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | OPTIMIZIRANA ANTITIJELA USMJERENA NA CD19 |
ExternalDocumentID | HRP20130314TT2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_HRP20130314TT23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:19:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Croatian English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_HRP20130314TT23 |
Notes | Application Number: HR2013P000314T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220805&DB=EPODOC&CC=HR&NR=P20130314T2 |
ParticipantIDs | epo_espacenet_HRP20130314TT2 |
PublicationCentury | 2000 |
PublicationDate | 20220805 |
PublicationDateYYYYMMDD | 2022-08-05 |
PublicationDate_xml | – month: 08 year: 2022 text: 20220805 day: 05 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Xencor Inc |
RelatedCompanies_xml | – name: Xencor Inc |
Score | 3.419962 |
Snippet | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
Title | OPTIMIZED ANTIBODIES THAT TARGET CD19 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220805&DB=EPODOC&locale=&CC=HR&NR=P20130314T2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKupNq2K1SkDNLZh9OQTJahSahDBK8VKyTFAELW3Ev--bIbWeehtm4M3Mg7d885YBuDGoUrZWy6K6JZV0p6klp7Y0qSqpXSm1rdm8ynWamsmz_jQzZgP4WNfC8D6hP7w5IkpUjfLecX292DxihTy3cnVXvePU131M3FDs0bGqogNkiKHvRnkWZoEYBG5SiGnh5ioL0WmKTlBf7zA_mjXaj158Vpay-G9T4kPYzZHcZ3cEg7flCPaD9ddrI9ib9hFvHPbCtzqG2ywnqGpeo1DwUvLoZ8yVE0jiEYF4xUNEhCBUnBO4jiMSJBLuN_-73TwpNmcjqnYKQ8T99AyE0my0SmkbS5apjiigrPTSsBpEBLYpt3Y7hsk2Sufbly_ggPGL57IZExh2y296ifa1q644X34BrL96rw |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKtabVsVq1YCaWzB70kOQrKbaLIRRipeQFUXQ0kb8-74MqfXU2zADb2YevOWbtwzAjVIJWa3VbVQ3qzh5UhbcpNAkLs8qPRcKXdJplWsQqv6z_DhX5j34WNfC0D6hP7Q5IkpUgfLeUH292DxiOTS3cnWXv-PU171HDIft0LEoogOksI5luHHkRDZr24afsGFixGIbopMEmaC-3tEQE1Ks9GK1ZSmL_zbFO4DdGMl9NofQe1sOYWCvv14bwl7QRbxx2Anf6ghuo5igqnl1HcYMydSKWleOIb5JGGImDy5hbEeYHMO15xLb53C_9O92qZ9szkZE6QT6iPurU2AytZRyoS41nq9kRAFZLmeKViIi0FW-1usRjLdROtu-fAUDnwSzdDYNn85hv-UdzWtTxtBvlt_VBdraJr-kPPoFjgV9mQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=OPTIMIZED+ANTIBODIES+THAT+TARGET+CD19&rft.inventor=Bernett%2C+Matthew+J&rft.inventor=Richards%2C+John+O&rft.inventor=Zhukovsky%2C+Eugene+Alexander&rft.inventor=Lazar%2C+Gregory+Alan&rft.inventor=Karki%2C+Sher+Bahadur&rft.inventor=Pong%2C+Erik+WeiKing&rft.inventor=Desjarlais%2C+John+R&rft.inventor=Chu%2C+Seung+Yup&rft.date=2022-08-05&rft.externalDBID=T2&rft.externalDocID=HRP20130314TT2 |